Dr. Ofer Merimsky
MD, Oncology
Deputy Director, The Oncology Institute
corporate_fareTel Aviv Sourasky Medical Center (Ichilov), Tel Aviv
Ofer Merimsky
MD, Oncology
Prof. Ofer Merimsky is a senior clinical oncologist and Deputy Director of the Oncology Institute at Tel Aviv Sourasky Medical Center (Ichilov), Israel. He holds a Clinical Full Professor appointment at Tel Aviv University Faculty of Medicine and has dedicated his career to the management of sarcoma, bone tumours, soft tissue tumours, GIST, and other rare cancers.
Prof. Merimsky completed his medical education at Hebrew University–Hadassah (1976–1983) and underwent formal oncology specialisation at Ichilov Hospital between 1988 and 2001. His Unit of Bone and Soft Tissue Oncology at Tel Aviv Sourasky Medical Center and Tel Aviv University has been the base for a substantial body of PubMed-indexed research, with Tel Aviv University crediting him with 217 research outputs spanning sarcoma chemotherapy, radiotherapy, limb-sparing treatment, mesothelioma, and GIST. His work is strongly interdisciplinary, drawing on pathology, imaging, systemic therapy, and radiation planning to deliver personalised care for complex and rare tumours.
CancerFax can coordinate medical-report review and consultation support for international patients seeking a specialist sarcoma or rare-tumour opinion from Prof. Merimsky, subject to hospital availability and case acceptance.
Why Consider Prof. Ofer Merimsky?
Prof. Merimsky brings over three decades of focused sarcoma and rare-tumour experience from one of Israel's foremost oncology institutions. His combined clinical and academic profile makes him especially relevant for patients with complex, uncommon, or refractory cancers who require expert multidisciplinary review.
Areas of Specialisation
Focused on sarcoma, bone and soft tissue tumours, GIST, and rare cancer management
Prof. Merimsky's clinical and research focus is centred on rare and complex solid tumours, particularly those arising in bone, soft tissue, and the gastrointestinal stromal compartment. His approach is evidence-based and multidisciplinary.
Sarcoma & Bone Tumours
Comprehensive management of soft tissue and bone sarcomas, including systemic therapy, limb-sparing strategies, and radiotherapy.
- arrow_rightSystemic chemotherapy for primary and metastatic soft tissue sarcoma
- arrow_rightLimb-sparing treatment combining surgery and adjuvant radiation therapy
- arrow_rightManagement of leiomyosarcoma, liposarcoma, synovial sarcoma, and rare subtypes
- arrow_rightRadiotherapy for spinal cord compression from sarcoma metastases
- arrow_rightOsteosarcoma and Ewing's sarcoma treatment planning
- arrow_rightChondrosarcoma including myxoid chondrosarcoma variants
- arrow_rightMultidisciplinary bone tumour board case coordination
GIST & Gastrointestinal Tumours
Diagnosis, systemic treatment, and follow-up for gastrointestinal stromal tumours aligned with ESMO clinical practice standards.
- arrow_rightSystemic therapy planning for localised and advanced GIST
- arrow_rightImatinib and subsequent-line targeted therapy for GIST
- arrow_rightFollow-up and surveillance in line with ESMO/European Sarcoma Network guidelines
Mesothelioma & Thoracic Oncology
Clinical and research involvement in malignant pleural mesothelioma and selected thoracic malignancies.
- arrow_rightSystemic treatment planning for pleural mesothelioma
- arrow_rightMolecular marker research in mesothelioma biology
- arrow_rightMultidisciplinary case review for thoracic rare tumours
Rare & Selected Tumours
Clinical management of uncommon tumour types requiring personalised, evidence-guided treatment strategies.
- arrow_rightKaposi's sarcoma
- arrow_rightTargeted therapy evaluation in selected rare sarcoma subtypes
- arrow_rightPost-traumatic soft tissue sarcoma
Procedures Performed
Clinical services and treatment approaches in sarcoma and rare tumour oncology
Prof. Merimsky's clinical services are anchored in the multidisciplinary management of bone, soft tissue, and rare tumours, including systemic chemotherapy, radiotherapy planning, limb-sparing approaches, and complex second-opinion review.
Sarcoma Systemic Treatment
Medical OncologyChemotherapy and systemic treatment planning for soft tissue and bone sarcomas.
GIST Targeted Therapy
Targeted TherapyTargeted agent planning and monitoring for gastrointestinal stromal tumours in line with ESMO standards.
Multidisciplinary Sarcoma Planning
MultidisciplinaryCoordinated case review and treatment planning across oncology, surgery, radiation, pathology, and rehabilitation.
Complex Case Diagnosis
DiagnosisPathology-led and imaging-supported diagnosis of rare and complex bone and soft tissue tumours.
Second Opinion Consultations
Second OpinionIndependent expert review for patients with sarcoma, GIST, mesothelioma, or rare tumours.
Research & Publications
Peer-reviewed contributions in sarcoma, GIST, mesothelioma, and rare tumour oncology
Prof. Merimsky has a substantial academic record in oncology. Tel Aviv University attributes 217 research outputs to his profile, spanning soft tissue and bone sarcoma, GIST, mesothelioma, limb-sparing radiotherapy, and rare tumour biology.
A full publication list is available through Tel Aviv University's research portal and PubMed. CancerFax can provide further information on Prof. Merimsky's research interests upon request.
Education & Training
Prof. Merimsky completed his medical training at Hebrew University–Hadassah and underwent formal oncology specialisation at Tel Aviv Sourasky Medical Center, followed by a long-standing academic appointment at Tel Aviv University.
Clinical Experience
Prof. Merimsky has spent his entire clinical and academic career at Tel Aviv Sourasky Medical Center and Tel Aviv University, building one of Israel's most specialised sarcoma and rare-tumour programmes.
Languages & International
Prof. Merimsky consults in the following verified languages.
CancerFax can coordinate professional medical interpreter support for international patients when required.
CancerFax can coordinate professional medical interpreter support for international patients requiring assistance in other languages.
How CancerFax Helps You Access Dr. Ofer Merimsky
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Ofer Merimsky's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Ofer Merimsky's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Ofer Merimsky before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Ofer Merimsky's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Ofer Merimsky's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Ofer Merimsky's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Ofer Merimsky
Prof. Ofer Merimsky is a senior oncologist and Deputy Director of the Oncology Institute at Tel Aviv Sourasky Medical Center (Ichilov), Israel. He is also a Clinical Full Professor in Oncology at Tel Aviv University and heads the Unit of Bone and Soft Tissue Oncology, with over three decades of experience in sarcoma and rare tumour management.
Prof. Merimsky specialises in soft tissue sarcoma, bone sarcoma (including osteosarcoma, Ewing's sarcoma, and chondrosarcoma), gastrointestinal stromal tumours (GIST), malignant pleural mesothelioma, Kaposi's sarcoma, and other rare or complex solid tumours. His published research also covers lung cancer and selected thoracic malignancies.
Prof. Merimsky is based at Tel Aviv Sourasky Medical Center, commonly known as Ichilov, in Tel Aviv, Israel — one of the country's leading academic medical centres. He is also affiliated with Tel Aviv University's Faculty of Medicine as a Clinical Full Professor.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert sarcoma or rare-tumour opinion from Prof. Merimsky, subject to hospital availability and individual case acceptance. Please submit your reports through CancerFax to begin the process.
Submit your medical reports, pathology findings, imaging results, and treatment history through CancerFax using the Send Your Reports option. The CancerFax team will review your documents, prepare a structured case summary, and coordinate the next steps with Prof. Merimsky's team at Tel Aviv Sourasky Medical Center, subject to availability.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, molecular findings, and full treatment history. Prof. Merimsky's expertise in rare and complex sarcomas makes him particularly relevant for cases where a diagnosis is uncertain or where standard treatments have not produced the expected response. The consultation format and availability depend on the hospital's scheduling.
Prof. Merimsky has a substantial research record in oncology. Tel Aviv University attributes 217 research outputs to his academic profile. His PubMed-indexed publications include work on gemcitabine for refractory sarcoma, radiotherapy for spinal cord compression from soft tissue sarcoma, limb-sparing approaches combining surgery and radiation, and GIST management as a collaborator on ESMO clinical practice guidelines.
Connect with Ofer Merimsky Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.